Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
Pathway Medical, With FDA Clearance in Hand, Starts Selling Device for Wiping Out Blockages in Leg Arteries
|
Luke Timmerman |
09/05/08 |
|
Seattle
|
|
Acucela Strikes Deal With Otsuka Pharmaceutical to Develop Drug for Eye Disease
|
Luke Timmerman |
09/04/08 |
|
Seattle
|
|
Targanta Antibiotic Shown Effective in Less-Frequent Dose
|
Luke Timmerman |
09/02/08 |
|
Boston
|
|
Dendreon Rival Suffers Meltdown, Investors Sitting Tight For Next Big Clinical Trial News
|
Luke Timmerman |
08/28/08 |
|
Seattle
|
|
Proteostasis Therapeutics Procures $45M, Stealthy Startup Gets Serious About Shampoo, MA Life Sciences Center Chief Shares Her Plans, & More Life Sciences News
|
Rebecca Zacks |
08/27/08 |
|
Boston
|
|
FDA Doesn’t Appear Overly Alarmed by Recent Cases of Brain Disease Associated With Tysabri; Working with Biogen Idec and Elan to Update Labeling
|
Luke Timmerman |
08/26/08 |
|
Boston
|
|
Dyax and Vertex Drugs Move Toward Market, Taligen Moves to MA, Covidien Moves Into Venture Territory, & More Life Sciences News
|
Rebecca Zacks |
08/20/08 |
|
Boston
|
|
Stromedix Drug Gets Orphan Status
|
Rebecca Zacks |
08/12/08 |
|
Boston
|
|
Amgen Looks to Biomarkers to Boost Its Batting Average in Developing New Drugs
|
Luke Timmerman |
08/07/08 |
|
National
|
|
Vertex Cystic Fibrosis Program on the Rise, Biogen and Partner Fall on Tysabri News, Alnylam Stakes RNAa IP Claim, & More Life Sciences News
|
Rebecca Zacks |
08/06/08 |
|
Boston
|
|
Biogen Idec, Elan Shares Plummet on News of Two PML Cases With Tysabri
|
Luke Timmerman |
08/01/08 |
|
Boston
|
|
Biogen Idec, Elan Report Two New Cases of Rare Brain Infection in Tysabri Patients
|
Luke Timmerman |
07/31/08 |
|
Boston
|
|
Dendreon Holds Its Breath, Big Provenge Clinical Trial Result Coming In October
|
Luke Timmerman |
07/31/08 |
|
Seattle
|
|
Epix CEO Resigns After Bumpy Road with Products for Depression, Alzheimer’s
|
Luke Timmerman |
07/28/08 |
|
Boston
|
|
Caliper Bets Future on Tools That Light Up Genes Before Researchers’ Eyes
|
Luke Timmerman |
07/28/08 |
|
Boston
|
|
RF Surgical Raises $8.2 million From Menlo Ventures and Stanford University
|
Luke Timmerman |
07/25/08 |
|
Seattle
|
|
Dendreon Expects Interim Provenge Trial Results in October
|
Luke Timmerman |
07/23/08 |
|
Seattle
|
|
Pathway Wins FDA Approval To Sell Blocked-Artery Buster
|
Luke Timmerman |
07/21/08 |
|
Seattle
|
|
Collegium Collects $20 Million in Venture Round, Led by Frazier
|
Luke Timmerman |
07/15/08 |
|
Boston
|
|
T2 Biosystems Diagnostic Holds Its Own In Comparison Against Hospital Tool
|
Luke Timmerman |
07/15/08 |
|
Boston
|
|
MediQuest Vying to Get First Drug Across FDA Goal Line, Put Raynaud’s in Your Vocabulary
|
Luke Timmerman |
07/15/08 |
|
Seattle
|
|
Infinity Pharmaceuticals Pulls Plug on Treatment for Prostate Cancer
|
Luke Timmerman |
07/14/08 |
|
Boston
|
|
Momenta Gets Some Mojo As FDA Agrees To Review Application of Generic MS Drug
|
Luke Timmerman |
07/11/08 |
|
Boston
|
|
Spiration, Uptake Medical Vying to Develop Better Emphysema Treatment
|
Luke Timmerman |
07/10/08 |
|
Seattle
|
|
Boston Scientific Wins Stent Approval, Resolvyx Moves Closer to Fish-Oil Drug Trials, Codon Cuts Algae Fuel Deal, & More Life Sciences News
|
Rebecca Zacks |
07/09/08 |
|
Boston
|
|
Boston Scientific Stent, With New Drug Coating, Wins FDA Approval
|
Luke Timmerman |
07/02/08 |
|
Boston
|
|
CVS Teams with Microsoft, Epix Makes Another Bid at Approval, Thermo Ups RNAi Ante, & More Life Sciences News
|
Rebecca Zacks |
07/02/08 |
|
Boston
|
|
Epix Resubmits Vasovist Application to FDA
|
Luke Timmerman |
07/01/08 |
|
Boston
|
|
MediQuest Therapeutics Persuades FDA to Do 6-Month Review of Lead Product
|
Luke Timmerman |
06/25/08 |
|
Seattle
|
|
Daily TIPS: Tech Policy Poll, Open-Source Healthcare, Tropical Disease, & More
|
Neil Savage |
06/25/08 |
Xconomist
|
National
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
